Linagliptin and Glimepiride Equally Effective for Adults with Type 2 Diabetes Mellitus

被引：0
|
作者：
Slawson, David C. [1 ]
机构：
[1] Univ N Carolina, Family Med, Charlotte, NC USA
来源：
AMERICAN FAMILY PHYSICIAN | 2020年 / 101卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
引用
收藏
页码：309 / 310
页数：2
相关论文
共 50 条
  • [31] Rationale and design of the CAROLINA® - cognition substudy: A randomised controlled trial on cognitive outcomes of linagliptin versus glimepiride in patients with type 2 diabetes mellitus
    Biessels G.J.
    Janssen J.
    van den Berg E.
    Zinman B.
    Espeland M.A.
    Mattheus M.
    Johansen O.E.
    BMC Neurology, 18 (1)
  • [32] Design and baseline characteristics of the CARdiovascular Outcome Trial of LINAgliptin Versus Glimepiride in Type 2 Diabetes (CAROLINA®)
    Marx, Nikolaus
    Rosenstock, Julio
    Kahn, Steven E.
    Zinman, Bernard
    Kastelein, John J.
    Lachin, John M.
    Espeland, Mark A.
    Bluhmki, Erich
    Mattheus, Michaela
    Ryckaert, Bart
    Patel, Sanjay
    Johansen, Odd Erik
    Woerle, Hans-Juergen
    DIABETES & VASCULAR DISEASE RESEARCH, 2015, 12 (03): : 164 - 174
  • [33] Linagliptin versus placebo followed by glimepiride in type 2 diabetes patients with moderate to severe renal impairment
    Groop, P. -H.
    Laakso, M.
    Rosenstock, J.
    Hehnke, U.
    Tamminen, I.
    Patel, S.
    von Eynatten, M.
    Woerle, H. -J.
    DIABETOLOGIA, 2013, 56 : S364 - S365
  • [34] Glimepiride administered once daily is equally effective as twice daily gliclazide for controlling blood glucose levels in patients with type 2 diabetes
    Lyness, W
    Tyler, J
    Lawrence, A
    DIABETES, 2001, 50 : A442 - A442
  • [35] Effect of Linagliptin on Structural Changes in the Kidney in Experimental Type 2 Diabetes Mellitus
    Yu. S. Gavrilova
    N. P. Bgatova
    V. V. Klimontov
    I. Yu. Ischenko
    S. V. Michurina
    N. E. Myakina
    E. L. Zavyalov
    Bulletin of Experimental Biology and Medicine, 2016, 161 : 501 - 504
  • [36] Empagliflozin and linagliptin combination therapy for treatment of patients with type 2 diabetes mellitus
    Triplitt, C.
    Solis-Herrera, C.
    Cersosimo, E.
    Abdul-Ghani, M.
    Defronzo, Ralph A.
    EXPERT OPINION ON PHARMACOTHERAPY, 2015, 16 (18) : 2819 - 2833
  • [37] Erratum to: Linagliptin: a review of its use in the management of type 2 diabetes mellitus
    Emma D. Deeks
    Drugs, 2013, 73 : 99 - 99
  • [38] Effect of Linagliptin on Structural Changes in the Kidney in Experimental Type 2 Diabetes Mellitus
    Gavrilova, Yu. S.
    Bgatova, N. P.
    Klimontov, V. V.
    Ischenko, I. Yu.
    Michurina, S. V.
    Myakina, N. E.
    Zavyalov, E. L.
    BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE, 2016, 161 (04) : 501 - 504
  • [39] Effects of pioglitzone and glimepiride on microvascular function in patients with diabetes mellitus type 2
    Forst, T
    Nguyen, M
    Langenfeld, M
    Friedrich, C
    Lübben, G
    Fennenkötter, U
    Kann, P
    Pfützner, A
    DIABETES, 2004, 53 : A308 - A308
  • [40] Optimization of therapy of type 2 diabetes mellitus with the oral hypoglycemic agent glimepiride
    Romantsova, T. I.
    Maksimova, N. V.
    DIABETES MELLITUS, 2010, 13 (01): : 50 - 54
12345